biote Corp. Announces Director Changes and New Officer Compensation
Ticker: BTMD · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1819253
| Field | Detail |
|---|---|
| Company | Biote CORP. (BTMD) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation, board-of-directors
TL;DR
biote Corp. swapped a director and gave its CMO a new pay package.
AI Summary
On June 5, 2025, biote Corp. filed an 8-K report detailing the departure of Director Dr. David G. Astrella and the appointment of Dr. Jonathan M. Weisberg as a new director. The company also announced a new compensatory arrangement for its Chief Medical Officer, Dr. Paul R. Savage, effective June 5, 2025.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Director changes and new compensation arrangements can introduce uncertainty regarding leadership stability and future strategic direction.
Key Players & Entities
- biote Corp. (company) — Registrant
- Dr. David G. Astrella (person) — Departing Director
- Dr. Jonathan M. Weisberg (person) — Newly Appointed Director
- Dr. Paul R. Savage (person) — Chief Medical Officer
- June 5, 2025 (date) — Effective date of changes
FAQ
Who has departed from the biote Corp. board of directors?
Dr. David G. Astrella has departed from the biote Corp. board of directors as of June 5, 2025.
Who has been appointed as a new director to the biote Corp. board?
Dr. Jonathan M. Weisberg has been appointed as a new director to the biote Corp. board, effective June 5, 2025.
What is the effective date of the reported changes?
The earliest event reported, including director changes and the new compensatory arrangement, is effective June 5, 2025.
What specific compensatory arrangement was announced?
The filing indicates a new compensatory arrangement for the Chief Medical Officer, Dr. Paul R. Savage, effective June 5, 2025.
What was biote Corp.'s former company name?
biote Corp.'s former company name was Haymaker Acquisition Corp. III.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 by Dr. David G. Astrella regarding biote Corp. (BTMD).